About MicroBiopharm Japan
MicroBiopharm Japan is a company based in Tokyo (Japan) founded in 2011.. MicroBiopharm Japan operates in a competitive market with competitors including Limula, PBS Biotech, m2p-labs, Membio and Innovel Intelligent Technology, among others.
- Headquarter Tokyo, Japan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of MicroBiopharm Japan
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2011 | Amount | Seed - MicroBiopharm Japan | Valuation | Toray Industries |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MicroBiopharm Japan
MicroBiopharm Japan has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Toray. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of Fibers, plastics, composite materials, optical fibers, resins for 3D printing
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MicroBiopharm Japan
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MicroBiopharm Japan
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Microbiopharm Japan Comparisons
Competitors of MicroBiopharm Japan
MicroBiopharm Japan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Limula, PBS Biotech, m2p-labs, Membio and Innovel Intelligent Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Modular solutions for on-demand cell therapy manufacturing are provided.
|
|
| domain | founded_year | HQ Location |
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies
|
|
| domain | founded_year | HQ Location |
Micro-bioreactors are provided for screening and bioprocess development.
|
|
| domain | founded_year | HQ Location |
Developer of single-use bioreactors for cell and gene therapies
|
|
| domain | founded_year | HQ Location |
Bioreactors and automated systems for cell culture production are supplied.
|
|
| domain | founded_year | HQ Location |
Recombinant hyaluronic acid is manufactured in varying molecular sizes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about MicroBiopharm Japan
When was MicroBiopharm Japan founded?
MicroBiopharm Japan was founded in 2011.
Where is MicroBiopharm Japan located?
MicroBiopharm Japan is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
What does MicroBiopharm Japan do?
MicroBiopharm Japan was founded in 2011 and is based in Tokyo, Japan. Contract research services are offered to biopharma companies, focusing on fermentation, strain development, and process optimization. Drug discovery is supported through libraries of microorganisms, P450 compounds for hydroxylation, and vitamin D derivatives. The portfolio encompasses anthracycline analogs, macrolide analogs, calcitriol, paricalcitol, pipecolic acid analogs, vitamin D analogues, and cyclodextrins within the biotechnology sector.
Who are the top competitors of MicroBiopharm Japan?
MicroBiopharm Japan's top competitors include PBS Biotech, m2p-labs and Limula.
Who are MicroBiopharm Japan's investors?
MicroBiopharm Japan has 1 investor. Key investors include Toray.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.